These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2113136)
1. [Clinical significance of the fourth component of complement assay]. Takemura S; Kondo M Nihon Rinsho; 1990 Feb; 48 Suppl():654-6. PubMed ID: 2113136 [No Abstract] [Full Text] [Related]
2. [Profile of the complement system in a family with hereditary angioedema]. Rivero S; Guzmán L Rev Med Chil; 1983 Nov; 111(11):1111-6. PubMed ID: 6431574 [No Abstract] [Full Text] [Related]
3. Nephelometric and immunodiffusion assays for the fourth component of complement in acquired C1 esterase inhibitor deficiency. Keil LB; DeBari VA Clin Chem; 1988 Feb; 34(2):427. PubMed ID: 3124983 [No Abstract] [Full Text] [Related]
11. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates. Doekes G; van Es LA; Daha MR Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866 [TBL] [Abstract][Full Text] [Related]
13. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function. Giclas PC J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566 [TBL] [Abstract][Full Text] [Related]
14. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies. Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316 [TBL] [Abstract][Full Text] [Related]
16. [C1 esterase inhibitor acquired deficiency: apropos of 4 cases]. Bergeron M; Lehner-Netsch G; Leblond PF; Brun G; Delâge JM Union Med Can; 1985 Apr; 114(4):346-9. PubMed ID: 4040289 [No Abstract] [Full Text] [Related]
17. Acquired C1-inhibitor deficiency. Frank M Behring Inst Mitt; 1989 Jul; (84):161-4. PubMed ID: 2679531 [No Abstract] [Full Text] [Related]
18. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)]. Roncato M; Vial MC; Maillet F; Peltier A Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575 [TBL] [Abstract][Full Text] [Related]
19. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer]. Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280 [No Abstract] [Full Text] [Related]
20. The role of C1, C1-inactivator and C4 in modulating immune precipitation. Schifferli JA; Steiger G; Schapira M Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]